5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) formulations
US11980605B1 · kind B1 · utility
2Cited by
1References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 1, 2023 |
| Grant date | May 14, 2024 |
| Priority date | — |
| Expiry date | Aug 1, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/19
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a dry powder formulation of 5-MeO-DMT or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable carriers or excipients. The formulations described herein may be used to treat a disease or condition, such as depression or alcohol use disorder in a subject in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.